TP53 R337H carriers were diagnosed with BC an average of 10 years older than patients who carried TP53 pathogenic variants within typical DNA-binding domain (42.2 ± 10.9 years vs. 32.3 ± 5.1 years, p < 0.007). Here, TP53 is linked to breast cancer.